Back

HIMS Stock

Live symbol workspace

HIMS market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $19.15
Trend Flat
Sentiment Neutral

Price Chart

📈
Loading chart for HIMS...
Powered by TradingView
{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support
$18.19
Resistance
$20.11

Volume & Momentum

Volume
Weak
0.8x avg
Momentum
0%
Weak

Technical Context

Current price
$19.15
RSI context
50

Market Sentiment

50
Neutral

Stock Metrics

Daily Vol
0%
VIX Est
20
Weekly
0%

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for HIMS skewed bearish (3 of 4 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%
— 0.0 pts vs previous week
Avg confidence across 14 calls in the last 7 days

What sources say

Bearish 3 articles
S&P 500, Nasdaq end lower as inflation, Iran tensions weigh
Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance
Hims Sales Miss on Rising Competition for Weight-Loss Drugs
Neutral 1 article
Earnings live updates: Plug Power, Hims & Hers set to kick off week of quarterly updates

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

HIMS News Intelligence (13 articles)

AI-curated news influencing HIMS price, sentiment, and trend

Explore All HIMS News with AI Analysis
Economy
3 weeks, 4 days ago

S&P 500, Nasdaq end lower as inflation, Iran tensions weigh

STORY: U.S. stocks ended mostly lower on Tuesday, but the Dow posted a modest gain, while the S&P 500 edged …

Impact on HIMS: The S&P 500 edged down slightly, while the Nasdaq lost 0.7%, as …
The S&P 500 and Nasdaq declined due to higher-than-expected inflation and ongoing Iran tensions, while … High (80%)
View full analysis →
Yahoo Finance 80% confidence
Stocks
3 weeks, 5 days ago

Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance

Hims & Hers reached a deal with Novo Nordisk in March to sell its GLP-1 weight loss drug Wegovy on …

Impact on HIMS: May pressure downward momentum
Financial market analysis indicating bearish sentiment based on current trends. Medium (60%)
View full analysis →
CNBC 60% confidence
Economy
3 weeks, 5 days ago

Hims Sales Miss on Rising Competition for Weight-Loss Drugs

Hims & Hers Health Inc. reported a first-quarter loss and sales that missed Wall Street estimates amid increasing competition in …

Impact on HIMS: May pressure downward momentum
Financial market analysis indicating bearish sentiment based on current trends. Medium (60%)
View full analysis →
Bloomberg 60% confidence
Economy
1 month, 2 weeks ago

Hims Yields Ground in GLP-1 Market. Why Its CEO Is Calling It the Netflix of Pharma.

Hims & Hers Health will allow providers to prescribe scripts filled by LillyDirect, Eli Lilly’s direct-to-consumer platform.

Impact on HIMS: Neutral market sentiment indicated
FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. High (94%)
View full analysis →
Yahoo Finance 94% confidence
🤖

AI Analysis

Multi-Provider AI Analysis

Neutral

AI Summary

Loading...

Confidence
0%
AI Model Multi-Provider AI Analysis
Open article